Lv1
80 积分 2024-07-18 加入
A novel anti-HER2/EGFR bispecific antibody–drug conjugate demonstrates promising antitumor efficacy and overcomes resistance to HER2- or EGFR-targeted ADCs
1个月前
已完结
Inhibitory Fc receptors modulate in vivo cytoxicity against tumor targets
8个月前
已完结
Development and evaluation of a human CD47/HER2 bispecific antibody for Trastuzumab-resistant breast cancer immunotherapy
8个月前
已完结
Expression and Purification of FGFR1-Fc Fusion Protein and Its Effects on Human Lung Squamous Carcinoma
8个月前
已完结
皖公网安备34019202002308
